EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Confirmation of Exome Sequencing Results Using Sanger Sequencing—Considerations in a Low‐Resource Setting

Nadja Louw, Samantha Schnell, Mhlekazi Molatoli, Ingrid Smit, Robyn Kerr, Koen Devriendt, Aimé Lumaka, Amanda Krause iD, Nadia Carstens iD, Zané Lombard, for DDD‐Africa as members of the H3Africa Consortium

Molecular Genetics & Genomic Medicine · 2026

DOI: 10.1002/mgg3.70224 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, 2026. Verfasst von Nadja Louw und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Human Genetics, National Health Laboratory Service, and School of Pathology, Faculty of Health Sciences, University of the Witwatersrand,…. Hauptthemen laut MEDLINE: Exome Sequencing, Developmental Disabilities, Genetic Testing, Sequence Analysis, DNA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NIMH NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Exome sequencing (ES) is now widely accepted as an appropriate first‐tier diagnostic test for developmental disorders (DD). International guidelines recommend that in diagnostic settings, ES findings be validated with an orthogonal method, such as Sanger sequencing, before reporting. However, more recent guidance recognizes that confirmatory testing for variants meeting strict quality criteria is redundant. Weighing up the cost to benefit ratio of this practice is crucial in settings where ES is not routinely implemented. The Deciphering Developmental Disorders in Africa (DDD‐Africa) study aims to enable equitable implementation of genomic medicine in low‐resourced settings, focusing on using ES in resolving DD in Africa.

Methods

We performed confirmatory Sanger sequencing for the first 64 probands (70 variants) that underwent ES in which a variant of interest was identified. Strict quality parameters were key to diminishing the observation of false‐positive variants.

Results

All high confidence variants identified by ES ( n = 38) were confirmed using Sanger sequencing and low confidence variants ( n = 32) were confirmed as false‐positive.

Conclusion

Confirming ES results with an orthogonal approach like Sanger sequencing is unnecessary in a resource‐limited setting when robust, context‐informed quality thresholds are applied. This recommendation removes significant barriers to the implementation of genomic medicine and allows for accelerated genomic access globally.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Exome SequencingDevelopmental DisabilitiesGenetic TestingSequence Analysis, DNAHumansResource-Limited SettingsExome

Stichwörter der Autor:innen

NGS quality metricsexome sequencinggenomic medicineresource‐limited settingssanger sequencingvariant confirmation

Autor:innen und Institutionen

  • Division of Human Genetics, National Health Laboratory Service, and School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Center for Human Genetics, University Hospitals, University of Leuven, Leuven, Belgium.
  • Center for Human Genetics, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
  • Department of Pediatrics, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
  • Genomics Platform, South African Medical Research Council, Cape Town, South Africa.
  • Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

ORCID-Profile: Amanda Krause, Nadia Carstens

Förderung

  • NIH HHS
  • NIMH NIH HHS
  • National Institutes of Health
  • National Institute of Mental Health

Zitieren

APA

Louw, N., Schnell, S., Molatoli, M., Smit, I., Kerr, R., Devriendt, K., Lumaka, A., Krause, A., Carstens, N., Lombard, Z., & for DDD‐Africa as members of the H3Africa Consortium (2026). Confirmation of Exome Sequencing Results Using Sanger Sequencing—Considerations in a Low‐Resource Setting. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.70224

Vancouver

Louw N, Schnell S, Molatoli M, Smit I, Kerr R, Devriendt K, et al. Confirmation of Exome Sequencing Results Using Sanger Sequencing—Considerations in a Low‐Resource Setting. Molecular Genetics & Genomic Medicine. 2026. doi:10.1002/mgg3.70224

BibTeX
@article{Louw2026,
  author = {Louw, Nadja and Schnell, Samantha and Molatoli, Mhlekazi and Smit, Ingrid and Kerr, Robyn and Devriendt, Koen and Lumaka, Aimé and Krause, Amanda and Carstens, Nadia and Lombard, Zané and for DDD‐Africa as members of the H3Africa Consortium, for DDD‐Africa as members of the H3Africa Consortium},
  title = {Confirmation of Exome Sequencing Results Using Sanger Sequencing—Considerations in a Low‐Resource Setting},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2026},
  doi = {10.1002/mgg3.70224}
}
Kostenlos starten →